Clinical Trials Browser

OTHER × Uveal Melanoma × tremelimumab × Clear all

NCT01034787 2017-10-27

Study of AntiCTLA4 in Patients With Unresectable or Metastatic Uveal Melanoma

Phase 2 Completed

Uveal Melanoma, Neoplasm Metastasis